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Cellular Genomic Maps Help Dissect Pathology
in Human Skin Disease
Asifa S. Haider1, Michelle A. Lowes1, Mayte Sua`rez-Farin˜as1, Lisa C. Zaba1, Irma Cardinale1,
Miroslav Blumenberg2 and James G. Krueger1
Genomic signature maps of different cell types can aid in the interpretation of genomic data of specimens
collected during disease states. We have defined ‘‘lineage-specific’’ genes, as well as ‘‘activation’’ genes, for
cellular components of the skin: keratinocytes, fibroblasts, macrophages, monocytes, T cells, immature, and
mature dendritic cells (DCs). Re-analysis of a previously published gene set of psoriasis then provided a model
for assessing the usefulness of these maps. We were able to ascribe over 90% of these genes to specific cell
types, and there was a surprisingly large contribution from DCs. This shows the utility of such cellular gene
maps.
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INTRODUCTION
Array-based techniques that profile genes expressed in
inflammatory and neoplastic skin diseases have become
important methods to characterize molecular alterations
associated with cutaneous pathology (Blumenberg, 2006).
With this genomic information, functional pathways that are
activated in diseased tissue can be delineated and dissected.
However, this objective requires prior classification of genes
into known categories. This may be based on a primary
knowledge of genes activated in signaling cascades, for
example a well-documented sequence of genes activated by
IFN-g signaling (Boehm et al., 1997). Alternatively, bioinfor-
matics programs can interrogate complex expression data
sets, for example Gene Ontology or pathway-organizing
computer programs.
Psoriasis vulgaris is one of the first skin diseases to be
classified through such expression profiling (Oestreicher
et al., 2001). Current whole-genome maps indicate that
41,300 genes are expressed differently in skin with psoriasis,
compared with the normal skin or non-lesional skin of the
same patient (Zhou et al., 2003; Haider et al., 2006). Within
the set of genes expressed in psoriasis, a strong signature
exists for IFN-g-regulated gene products (B63 genes) (Lew
et al., 2004). Many other cytokines and inflammatory
products can be identified and put into provisional networks
(Liu et al., 2007). A broader analysis of the expressed genes
using Gene Ontology annotations enables researchers to
classify the functional categories of genes (Zhou et al., 2003);
however, this provides no information on the associated cell
types.
Interpretation of complex genomic sets derived by array-
based methods is currently limited because signatures of
specific cell sets that make-up resident or infiltrating
populations are mostly unknown. In this study we used a
single-gene expression platform (Affymetrix U95Av2 arrays)
to derive cell-specific gene lineage maps for several types of
cells that are found in the skin during cutaneous inflammatory
processes. We have developed such maps for keratinocytes,
fibroblasts, macrophages, monocytes, T cells, and immature
and mature dendritic cells (DCs). Peripheral blood mono-
nuclear cells (PBMCs) were also included as some subsets of
infiltrating or resident leukocytes might not have been
represented in this list. In addition, gene sets, which were
associated with the activation of T cells and PBMCs through
CD3/CD28 ligation or with the activation of keratinocytes in
the presence of cytokines, were also codified.
In the case of psoriasis, the growth and differentiation of
resident cells is altered, in addition, the skin is heavily
infiltrated by T cells, CD11cþ myeloid DCs, and by smaller
populations of other types of leukocytes (Krueger, 2002;
Lowes et al., 2005). Earlier work with arrays or expression
tags has identified many genes, which are altered by the
activation of T cells (Diehn et al., 2002) or by the progressive
differentiation of myeloid DCs (Teague et al., 1999;
Hashimoto et al., 2000), but gene sets that are unique or
classify diverse cell lineages are largely unavailable. We
illustrate how the use of these gene array-derived cell-specific
maps can be used to further classify the disease-related gene
set in psoriasis. Using our lineage and activation genomic
maps, we can now assess 490% of expression changes in
psoriasis to specific cell sets or to activated cells. These new
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data significantly advance our understanding of the biologic
processes in psoriasis, and can be applied to other cutaneous
diseases. Overall, our approach argues for developing yet
more extensive and more complete genomic maps to classify
biologic processes in skin diseases in a comprehensive
fashion.
RESULTS
Defining genes expressed in keratinocytes, fibroblasts,
macrophages, monocytes, T cells, and immature and mature
DCs
Psoriasis vulgaris, atopic dermatitis, and other inflammatory
skin diseases are characterized by significant increases in
infiltrating leukocytes such as T cells and DCs, as well as
altered growth of resident skin cells. In this study, we elected
to study T cells, several types of myeloid leukocytes, for
example monocytes, macrophages, and DCs, as well as
keratinocytes and fibroblasts, for patterns of gene expression.
Using Affymetrix U95Av2 GeneChips, we quantified the
expressions of B12,000 known genes using several inde-
pendent isolates of each cell type for all the analyses. All the
genes that were expressed in at least one cell type were
codified and relative levels of gene expression were
compared using analysis of variance with a correction for
multiple comparisons. Genes in which expression was
different (Po0.05) from at least one other cell ‘‘lineage’’
were selected by this method. We then assembled the genes
into cell sets and recognized that some genes were highly
expressed only in one cell type, whereas other genes were
expressed in two or more cell types. Genes with expression
above our selection threshold (see Materials and Methods) in
only one cell type were classified as cell-specific genes for
that cell type, whereas other genes were classified into two or
more cell types. A set of genes common to myeloid
leukocytes was also identified and these genes can be
considered to be lineage-related for myeloid cells.
With this approach we defined broad sets of genes with
restricted expression in one cell type only: 513 genes in
keratinocytes, 633 genes in fibroblasts, 286 genes in
macrophages, 602 genes in monocytes, 770 genes in T cells,
and 377 genes in DCs (Figure 1a). A complete list of all the
genes in each cell type is available in Tables S1A–6. Of the
377 genes in DCs, 59 genes were common to both immature
and mature DCs, 95 genes were specific to immature DCs,
and 223 genes had higher expression in mature DCs (Figure
1b). These gene lists are listed in Table S6A. To confirm that
these lists were applicable to each specific cell type, we
evaluated the level of expression of known (based on the
literature) genes in each cell type. The blue areas in Figure 1c
highlight this expression, showing that known representative
genes are indeed increased in each cell type compared with
other types of cells.
Common genes in cell groups
We also detected groups of genes with higher expression
levels in more than one cell type (Figure 2a), and these could
be combined into biologically relevant groups of cells. We
considered these in four groups: (a) genes commonly
expressed in myeloid cells (547 genes); (b) genes in skin
resident cells (fibroblasts and keratinocytes; 385 genes); (c)
leukocyte signature genes (681 genes), and (d) genes in
multiple cells (744 cells). Complete lists of genes are
available in Tables S7A–S10. The blue areas in Figure 2b
highlight the expression of genes known to be present in
these groups of cells, and help validate the genes that we
were able to define with this approach. The majority of
increased genes had not been previously associated with
these cell families.
Defining cell activation genes
To understand the contribution that activated cells play in
inflammatory dermatoses, we developed maps of CD3/
CD28-activated T cells and PBMCs for 24 hours (Figure 3a).
Activated PBMCs were included as they might be more
representative of the mixtures of cells infiltrating the skin
during inflammation. As the selection of activation genes
required a comparison of two different conditions within the
same cell type, we selected activation genes with 1.2-fold
higher expression when compared with control. We detected
a set of 41,100 genes in activated isolated T cells, and
41,600 genes in activated PBMCs. There were 735 genes
commonly activated in the two populations of cells (Table
S12A for gene lists). A subset of these genes is listed in Figure
3c. As expected, activated PBMCs contain a mixture of genes,
which were not detected in purified T cell preparations.
Several of the highly upregulated genes unique to activated
PBMCs, for example MMP-12, CCL8, CD1B, and CCL18,
were gene products detected only in myeloid DCs and were
not typically associated with T cells.
To confirm this concept of lineage- and activation-specific
genes, we performed RT-PCR on these populations for
selected genes (Figure 4). The expression of CD3D was
stable during activation, whereas those of lymphotoxin-a and
IFN-g were clearly increased. Similarly, CD11c was consis-
tently expressed in the common myeloid cell group, but
DCs-lysosomal-associated membrane protein (LAMP) and
indoleamine-pyrrole 2,3-dioxygenase were markers for ma-
ture/activated DCs.
Using published gene sets (Banno et al., 2003, 2004), we
reanalyzed the gene expression in keratinocytes in response
to IFN-g and tumor necrosis factor (TNF) cytokines at 1, 4, 24,
and 48 hours (Table S13A–15). There were 606 genes
upregulated by IFN-g, the majority of which were upregu-
lated at 24–48 hours. In response to TNF, 258 genes were
upregulated in keratinocytes. We found 112 genes that were
commonly regulated by the two cytokines, whereas 494
genes were uniquely regulated by IFN-g and 146 uniquely to
TNF.
Re-classification of a common inflammatory dermatosis using
cell-specific gene maps: psoriasis vulgaris
Psoriasis is an ideal disease to evaluate the usefulness of these
cellular genomic maps, as it is one of the few inflammatory
dermatoses with published gene sets. Earlier genomic
analyses of psoriasis used Gene Ontology annotation to
identify the function of B425 genes out of the 1,300
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regulated genes (Zhou et al., 2003), leaving4800 genes with
unknown function. With the cell genomic maps presented in
this study, it is now possible to associate B90% of the
psoriasis genes with different cell types. In this study we
analyzed untreated psoriasis lesions of eight patients using
U95Av2 GeneChips and found that 1,210 genes were
upregulated in psoriasis. The statistical analysis of this data
set has been published previously (Haider et al., 2006).
Table 1 gives a quantitative overview of the number of genes
that were present in psoriasis and can be associated with
different cell types.
We classified the genes upregulated in psoriasis into two
categories: lineage genes that were expressed in resting cells
(Table 1a), and genes that were upregulated after the
activation of cells in the presence of anti-CD3/CD28
antibodies and cytokines such as IFN-g and TNF, or after
activation due to the maturation of DCs (Table 1b). Some of
the genes that were expressed in resting cells were also
expressed in activated cells. Thus, we further defined genes
that were uniquely expressed in activated cells and not
expressed in resting cells. Of the 1,210 genes that were
upregulated in psoriasis, we were able to classify 490% of
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Figure 1. Defining genes expressed in keratinocytes, fibroblasts, macrophages, monocytes, T cells, and immature and mature DCs. mRNA from cultured cells
was hybridized to individual oligonucleotide arrays containing B12,000 human genes (Affymetrix HG-U95Av2 chips). Heatmaps show unsupervised
hierarchical clusters of upregulated genes in individual cell types (41.5-folds compared with other cell types; Po0.05, n¼2–4) using the similarity measure:
Pearson’s correlation. Areas of clusters in red for individual cell types define the number of upregulated cell lineage genes (number shown in parenthesis),
compared with green areas with lower expressions of same genes (horizontally) in other cell types. (a) Lineage genes in keratinocytes, fibroblasts, macrophages,
monocytes, T cells, and DCs. (b) DCs cluster: lineage DCs genes before (immature DCs) or after maturation (mature mDCs). (c) Examples of normalized gene
expression corresponding to the cell types described in (a) and (b). The expressions of the representative cell lineage genes are 1.5-fold greater than in all other
cell types (blue areas) (Tables S1A–6 list all genes).
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genes: 974 genes were lineage-specific and 121 were
uniquely associated with cellular activation (gene lists are
available in Tables S1B–2).
We had previously identified B63 psoriasis genes from
the literature as being associated with the IFN-g pathway
(Lew et al., 2004). Our current analysis of all the psoriasis
genes defined many more IFN-g-associated genes (143) to be
uniquely regulated by IFN-g. To our surprise there were fewer
psoriasis genes (27) that were regulated either uniquely by
TNF or in combination with IFN-g (40).
We further cell-typed other cytokines, chemokines, and
proinflammatory genes in psoriasis (Figure 5). Several key
observations can be made. A combination of cell types,
rather than a single cell type, contributed these genes. The
expression of these cytokines was highly represented in the
common myeloid cells (B60%). The majority of genes
expressed in DCs were associated with mature DCs rather
than immature DCs. Approximately 40% of these genes were
associated with T cell activation. Many genes in keratinocytes
were uniquely expressed in response to IFN-g. Several genes
were commonly regulated by cytokines such as IFN-g, TNF,
or IL-20, which suggests an important role of these genes in
psoriatic epidermal hyperplasia.
Our analysis revealed that the majority of genes in
psoriasis were expressed simultaneously in different cell
types. However, we were also able to determine which
proinflammatory genes in psoriasis were uniquely expressed
in either resting or activated cells. We were able to identify
b
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Figure 2. Common genes in cell groups. mRNA from cultured cells was hybridized to individual oligonucleotide arrays containing B12,000 human genes
(Affymetrix HG-U95Av2 chips). Heatmaps show unsupervised hierarchical clusters of upregulated genes in cell groups (41.5-folds compared with other
cell type; Po0.05, n¼ 2–4) using the similarity measure: Pearson’s correlation. Areas of clusters in red for individual cell groups define the number of
upregulated cell lineage genes (number shown in parenthesis) compared with green areas with lower expressions of the same genes (horizontally) in other cell
types. (a) Common myeloid cells (DCs, macrophages, and monocytes), b skin-resident cells (fibroblasts and keratinocytes) (c) leukocytes (monocytes,
macrophages, DCs, and T cells), and d multiple cells (DCs, monocytes macrophages, T cells, fibroblasts, or keratinocytes). (b) Examples of normalized gene
expressions of the cell groups described in (a). The expressions of the representative group lineage genes are 1.5-fold greater than in other cell types (blue areas)
(Tables S7A–10 list all genes).
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several cytokines (Figure 5) to be uniquely expressed in
fibroblasts (cehmokine (C-X-C-motif) Ligand 12 (CXCL12),
fibroblast growth factor 2, and nerve growth factor-b), T cells
(IL-4 and LIB), and monocytes (S100A12). We were also able
to classify genes like CXCL1, DEFB4, and IL-12B that were
expressed uniquely in activated cells like mature DCs,
activated T cells and TNF, IFN-g, or IL-20-induced genes in
keratinocytes (gray highlighted genes in Figure 5).
DISCUSSION
In this study, we profiled the genes expressed in multiple cell
types that were associated with the skin in a steady state, and
also the cell types that infiltrate the skin in inflammatory
diseases. This approach leads to the identification of
relatively large sets of genes that have their expression
restricted to one cell type (lineage genes) or to groups of
related cells. Furthermore, this innovative approach gives an
overview of the genes, and the associated cell types of a
diseased tissue. These gene lists contain not only known
genes that have been previously used to classify unique cell
lineages, for example expression of CD3 (T cell receptor) in
T cells or keratins in keratinocytes, but also many other genes
not previously appreciated as having cellular restriction. In
addition, we identified genes that were uniquely associated
with specific activation or differentiation states of cells
(activation genes), that is leukocyte activation, cytokine-
induced transcriptional activation of keratinocytes, and
maturation/activation of dendritic antigen-presenting cells.
The sum of these data provide a set of cell lineage and
activation genomic maps that can be used to help dissect
cellular processes, which occur in a wide range of skin
diseases. Complete lists of cell lineage and activation gene
sets are provided as Supplementary Material in this report, so
that researchers working on skin diseases can have ready
access to the needed data sets.
Microarrays provide excellent tools to identify genes for
many functions: interpreting cell types in a given disease,
classification of disease ‘‘signatures’’, describing biological
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Figure 3. Defining cell activation genes. mRNA from cultured cells was hybridized to individual oligonucleotide arrays containing B12,000 human genes
(Affymetrix HG-U95Av2 chips). Heatmaps show unsupervised hierarchical clusters of upregulated genes in activated cells (41.2-fold compared with
control; Po0.05, n¼2) using the similarity measure: Pearson’s correlation. Areas of clusters in red for activation genes define the number of upregulated
genes (number shown in parenthesis) as compared with green areas with lower expressions of the same genes (horizontally) in controls. (a) Genes found in
anti-CD3/CD28-treated T cells and PBMCs, (b) Venn diagram describes the number of unique and common genes in activated cells. (c) Examples of normalized
gene expressions in activated T cells and PBMCs. Ratios of gene expressions of selected genes in each activated cell type compared with control are greater
than 1.2-fold in treated versus control (Po0.05,n¼ 2), ND¼ not detected. (Table S12A lists all genes).
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pathways, estimating clinical outcomes, and also predicting
response to drugs. In a seminal study, Golub et al. (1999)
predicted the cellular contribution in leukemia as being
either myeloid or lymphoid using array data. Cutaneous
diseases have also been characterized to determine their
‘‘genomic signature’’ such as basal cell carcinoma (O’Dris-
coll et al., 2006), squamous cell carcinoma (Haider et al.,
2006; Nindl et al., 2006), and atopic dermatitis (Nomura
et al., 2003). The role of pathways and cytokines such as IFN-g
has been deduced from microarray data (Crow et al., 2003).
Predictions of clinical outcomes are becoming possible by
meta-analyses of microarray data sets, such as cancer survival
(Lyman and Kuderer, 2006). Some efforts have been also
made to describe responses to cancer drugs based on array
data (Cheok et al., 2003). A database of gene-expression
signatures of human diseases and their responses to
therapeutic drugs may be a useful tool and should be made
available to scientists. Integration of such a database has been
conceptualized by Gullans (2006). ‘‘Connectivity maps’’ are
an example of this approach and contain gene-expression
profiles of human cells lines cultured in vitro and exposed to
different small bioactive molecules (Lamb et al., 2006). These
maps led to the proposal of a combination of dexamethasone
and sirolimus as an effective approach in the treatment of
acute lymphoblastic leukemia. All these uses of microarray
data will be enhanced by the application and correlation of
our cell maps to array analysis.
In this study, we illustrate how lineage and activation gene
maps can be applied to inflammatory dermatoses by re-
analyzing genomic data in psoriasis vulgaris. Our expanded
analysis produces expected and unexpected results. Given
that many different cell types contribute to the histopathology
of psoriasis, it is not a major surprise to find that gene
products of many different cell types contribute to the
summed genomic signature (41,200 genes), generated from
profiling biopsies of full-thickness skin lesions. From the
standpoint of cell types that produce cytokines, chemokines,
and other inflammatory products, it is also clear that this
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global inflammatory environment is produced by many
different cell types, with a strong likelihood that paracrine
effects of these products produce a dense web of cytokine:
cell interactions take place in ways that are interdependent
and interactive for this specific disease state. At the genomic
level, cell lineage gene maps produce a view of molecular
pathogenesis that is somewhat different from the view
generated by immunohistochemical phenotyping of disease-
associated cellular alterations. In terms of infiltrating leuko-
cytes, psoriasis contains quite large populations of both
T lymphocytes and CD11cþ DCs, with a slight numerical
advantage of the T cells (Lowes et al., 2005). At the level of
gene expression, the signature of CD11cþ myeloid cells and
DCs is much more prominent than that of T cells, with about
a 5:1 ratio of myeloid versus T cell expressed genes being
measured. Clearly, activation products of both T cells and
DCs are present, which argues that both cell lineages are
intimately involved in molecular pathogenesis. However, the
very large number of expressed genes, which are associated
with activated/mature DCs, bolsters the emerging view that
inflammatory DCs and mature DCs are key cell types in the
pathogenesis of psoriasis (Lowes et al., 2005, 2007; Nestle
et al., 2005).
Use of our genomic cellular maps helps dissect disease
pathology. These must be considered as a starting point to
illustrate the principle that having this type of information
may be important to understanding the molecular pathology
of skin diseases. If progress along this pathway is to continue,
then much more work will be needed to develop more
accurate and precise maps of all cell types that are found in
the skin. In our approach, we analyzed cell types that could
be obtained in abundant quantities from a culture of blood or
skin in vitro. These cell sets are almost certainly different from
in vivo counterparts in critical ways, for example in the use of
selective growth factors or cytokines to obtain the cell
populations or in the differentiation states attained. The
genes, for example, expressed in cultured keratinocytes will
clearly have fewer differentiation-specific genes for terminal
stages of corneocyte differentiation. In addition, there are
many cell types in the skin that we have not incorporated into
this early analysis and with the addition of those cell types,
for example endothelial cells, smooth muscle cells, or
melanocytes, the lineage gene lists we show are likely to
become smaller and more specific. We believe that this line
of work should be extended, as we are at a scientific junction
where skin diseases may be more accurately defined by
genomics than by conventional histopathology and where
therapeutic approaches may be guided by the molecular
definition of diseases.
MATERIALS AND METHODS
The Institutional Review Board’s approval was obtained before
inviting healthy volunteers or patients with psoriasis to participate in
the study. Informed consent was obtained from volunteers and
patients before their participation, and the study was performed with
strict adherence to the Declaration of Helsinki Principles.
Skin samples and cell cultures
Skin punch biopsies from psoriasis lesional and non-lesional skin
were obtained from eight patients with psoriasis as described
previously (Bowcock et al., 2001). Comparison of these groups with
normal skin was beyond the scope of this paper. Major inclusion
criteria were: involvement of psoriasis vulgaris of 410% body
surface area, no systemic treatment for at least 4 weeks nor topical
treatment for at least 2 weeks before entering the study, no
significant infections or immune suppression, and no significant
renal, hepatic, or other medical disease.
PBMCs and T cells: PBMCs from two donors were isolated from
heparinized human blood using Ficoll-Paque Plus according to the
standard protocol. T cells were negatively isolated using Dynals
Table 1. Number of psoriasis genes in disease-
associated cell types
Cell types Genes upregulated in P/NL (1210)
(a) Lineage genes
Monocyte 69
Macrophages 35
DC 18
Common myeloid 115
Leukocytes 83
T cells 58
Fibroblasts 44
Keratinocytes 118
Skin-resident cells 64
Multiple cells 115
Housekeeping 255
Total lineage 974
(b) Unique activation
Cytokine activation (35)
Unique cytokine (not T cell
activation)
12
T cell activation (PBMC or T cell)
(93)
Unique T cell activation (not
cytokine activation)
59
Common cytokine, T cell
activation, or
mDC
38
mDC (40)
Unique mDC 12
Total unique activation 121
(c) Summary
Not classified 115
Total psoriasis genes 1,210
% classified 90.5
DC, dendritic cells; mDC, mature mDC; PBMC, peripheral blood
mononuclear cells.
Overview of number of genes contributed by different cell types and
groups (presented in Figures 1–3) that are associated with psoriasis genes.
Complete list of all genes is in Table BS1 and S2.
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T-Cells Negative Isolation Kit (Dynal Biotech, Invitrogen
Corp, Carlsbad, CA, Cat. no. 113–11D) according to the manufac-
turer’s protocol. Non-stimulated PBMCs or T cells served as
control to stimulation with anti-CD3/CD28 using Dynabeadss
CD3/CD28 T Expander (Dynal Biotech) according to the manufac-
turer’s protocol. All reagents were added at time 0 and cells and
supernatant were collected at 24 hours after stimulation. Activated
PBMCs and T cell phenotype were confirmed by flow cytometry
(CD69 expression on CD3þ cells). PBMCs or T cells were isolated
and stored at 801C until required, as described previously
(Chamian et al., 2005).
Monocytes: Monocytes were obtained from three donors
as described previously (Wang et al., 2006). Leukocyte-enriched
blood was obtained from the New York Blood Bank, and
processed as above to obtain PBMCs. Monocytes were isolated
from PBMCs using a Monocyte Negative Isolation Kit (Dynal
Biotech). Monocyte phenotype was confirmed by flow cytometry
(CD14 expression).
DCs: In vitro-derived DCs from three donors were generated as
described previously (Lee et al., 2002). Immature and mature DCs
phenotype was confirmed by flow cytometry (CD86þCD83lo and
CD86þCD83hi, respectively).
Macrophages: In vitro-derived macrophages from two donors (in
duplicates) were generated frommonocytes by a standard method (Davis
and Gordon, 2005). Macrophage phenotype was confirmed by flow
cytometry (CD11bþ , CD11cþ , CD68þ , HLA-DRþ , CD86þ , C83).
Fibroblasts: Fibroblasts from two donors were grown from
isolated foreskin and cultured in Dulbecco’s modified Eagle’s
medium (Gibco-BRL Life Technologies, Gaithersburg, MD) þ 10%
heat-inactivated human serum (Hyclone, Invitrogen Corp,
Symbol
CCL2, MCP1 * * * I, IL20 *
CCL3, MIP1a + *
CCL4, MIP1b + *
CCL5, RANTES * Tor I
CCL17, TARC IL20
CCL18, PARC *
CCL19, MIP3b *
CCL20, MIP3a + * T, IL20
CCL21, SCYA21 *
CCL27, CTACK T
CD83 + * T, IL20
CD8A
CX3CL1, Fractalkine * * I, IL20
CXCL1, Gro-a T, IL20
CXCL2, Gro2 * * * Tor I
CXCL5, ScyB5 *
CXCL9, MIG I
CXCL10, IP-10 + I
CXCL11, I-TAC I
CXCL12, SDF1a
CXCL13, ScyB13 *
CTSC, cathepsin C Tor I
CTSL, cathepsin L I
DEFB4 I
ECGF1 * T, I, IL20
ET1 * Tor I
FCGR1A, CD64
FCGR3A, CD16
FGF2
FGF7, KGF
GZMA
GZMB +
HCK
NGFB
PDGFA +
PDGFB
VEGF +
GMCSF +
IFNG +
IL-1b * T
IL-1RN
IL-4 +
IL-6 *
IL-7 *
IL-8 * T, IL20
IL-10 +
IL-11
IL-12B *
IL-12RB2 + I
IL-15 * I
IL-18 *
IL-13RA1 + * T
IL-15RA + * I, IL20
IL-4R + * I
INDO * I
IRF1 Tor I
IRF2 *
ICAM1 I
ICOS +
ITGA2, integrin a 2
ITGA6, integrin a 6
ITGAL, CD11a
ITGB2, integrin, b2
ITGB4, integrin, b4
ITGB4BP I
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DC-LAMP, LAMP3 I
LTB
MMP1 I
MMP9
MMP12
MIF + * *
MX1 I
NFKB1 + Tor I
NOS2C
NOS3
OAS1
OSM, oncostatin M 
REL, c-Rel +
S100A2
S100A3
S100A4
S100A7
S100A8
S100A9
S100A10
S100A12
S100A13
S100A14 * *
S100P
SERPINA3 T
SCYE1
STAT1 I, IL20
STAT3
STAT5B +
TNF + T
 TGFB1
 TLR2
 TNFRSF21
 TNFRSF4, CX40
 TNFRSF7, CD27
 TNFSF10, TRAIL Tor I
 TRA@
 TRAF3 +
Figure 5. Cytokines, chemokines, and proinflammatory genes in resting and activated cells in psoriasis. Black highlights describe the presence of the gene in
the listed cell types. (þ ): activation genes in T cells (*): genes expressed in mature DCs. T: genes induced by TNF in keratinocytes. I: genes induced by IFN-g in
keratinocytes; IL-20: genes induced by IL-20 in keratinocytes. Grey highlight: genes uniquely expressed in activated cells.
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SH30071.03,) and PenStrep (Penicillin 10 kU/ml, Streptomycin
10mg/ml) (Invitrogen Corp. Carlsbad, CA, Cat. no. 15140–148).
Cultures were set up in 100ml/dish (Corning, NY, Cat. no. 25020)
until confluent.
The cultured cells were lysed with 2ml per dish of Rneasy lysis
buffer (RLT) buffer (Qiagen, Valencia, CA; plus10 ml/ml 2-mercapto
ethanol), and stored at 801C for later RNA preparation.
Cell phenotypes
PBMCs and T cell activation, monocytes, DCs, macrophage.
Cells were stained for 15minutes at room temperature with the
following antibodies to phenotype: monocytes, CD14; PBMCs and
T-cell activation, CD69 and CD3 (Becton Dickinson, San Jose, CA);
DCs, CD86 (Becton Dickinson) and CD83 (Immunetech, Westbrook,
ME); macrophages, CD86 (Becton Dickinson), CD83 (Immunetech),
CD11b (Becton Dickinson), CD11c (BioLegend, San Diego, CA),
CD68 (DakoCytomation, Dako, Carpinteria, CA) and HLA-DR
(Becton Dickinson) conjugated to either phycoerythrin, peridinin-
chlorophyll-protein, or allophycocyanin (Becton Dickinson) as
described previously (Chamian et al., 2005).
Microarray analysis
RNA was extracted from the samples as published previously (Haider
et al., 2006). U95Av2-set GeneChip probe microarrays (Affymetrix
Inc., Santa Clara, CA) were used containing probe sets representing
approximately 12,000 genes. Fragmentation and array hybridization
were carried out according to the manufacturer’s instructions
(Affymetrix Inc.). The raw data of control and cytokine-activated
(TNF and IFN-g) keratinocytes microarray was used from a previous
publication (Banno et al., 2003, 2004). The raw GeneChip data for
psoriasis has also been published previously (Haider et al., 2006).
Scanning and quality control, GeneChip expression value analysis,
hierarchical clustering, and heatmaps were performed as described
previously (Haider et al., 2006). A heatmap of the computed tree
represents unsupervised hierarchical clustering and is presented by red
and green lines. Each line presents genes with relatively upregulated
(red) or downregulated (green) expression value in fold changes. Gene
Ontology annotations of differentially expressed genes were collected
from LocusLink (http://www.ncbi.nlm.nih.gov/LocusLink).
Cell lineage classification and statistical analysis
The determination of the cell lineage maps involved two steps. First,
expression values were analyzed with a one-way analysis of
variance using cell types as factors. P-values were adjusted for
multiple hypothesis testing using the Benjamini–Hoechberg proce-
dure. Genes with false discovery rate o0.05 were considered for
further analysis. These sets of genes (7,909 genes) were the ones
where the mean expression values differ in at least one of the factors
and was further subjected to the second step: selection of genes that
defined lineage characteristic of a cell type or cell group. This was
achieved by arbitrarily taking 1.5 as the normalized mean expression
value or as a cutoff number such that any gene that was expressed at
1.5 or higher value in a cell type or cell group compared with each
and all other cell types was defined as lineage gene.
The following conditions were defined:
(1) Lineage genes in the following cell types: keratinocytes,
fibroblasts, macrophages, monocytes, T cells, and immature
and mature DCs.
(2) Common genes in the following cell groups:
a. common myeloid cells (DCs, macrophages, and monocytes),
b. skin-resident cells (fibroblasts and keratinocytes)
c. leukocytes (monocytes, macrophages, DCs, and T cells)
d. multiple cells (DCs, monocytes macrophages, T cells, fibro-
blasts, and keratinocytes).
Housekeeping: gene expressed in lower than the 1.5 normalized
expression value in all cell types.
Gene lists for these analyses are available in Table S1.
Cell activation classification
To look for genes that were significantly different between activated
cells and controls, a one-way analysis of variance was used. P-values
were adjusted for multiple hypothesis testing using the Benjamini–-
Hoechberg procedure and genes with false discovery rate o0.05
and fold change of 1.2 or above were considered.
The following conditions were defined:
(1) T cell and PBMCs activation genes: genes expressed in anti-
CD3/CD28-treated T cells and PBMCs were compared with
those in untreated controls.
(2) Cytokine activation of keratinocytes: genes expressed in
TNF and IFN-g-treated keratinocytes were compared with those
in untreated controls.
Gene lists for these analyses are available in Table S1A.
Re-classification of a common inflammatory dermatosis using
cell-specific gene maps: psoriasis vulgaris
Genes upregulated in psoriasis lesional versus non-lesional were
classified into lineage genes, as obtained from the analysis above.
Gene lists are available in Table S1B.
Expression changes in mRNA with real-time RT-PCR analysis
The primers and probes for these genes for the TaqMan RT-PCR
assays were generated with the Primer Express algorithm, version
1.0, using published genetic sequences (NCBI-PubMed) for each
gene. The human acidic ribosomal protein (hARP) gene, a house-
keeping gene, was used to normalize the expression of each gene.
The primer sequences for hARP and IFN-g have been published
(Chamian et al., 2005). The primers for certain genes were designed
by Applied Biosystems (Foster City, CA): CD3D (assay ID
Hs00174158_m1) and indoleamine-pyrrole 2,3-dioxygenase (assay
ID Hs00158027_m1). All primers were purchased from Applied
Biosystems: lymphotoxin-a forward, TTGGCCTCACACCTTCAGCT;
lymphotoxin-a reverse, TGCTGTGGGCAAGATGCA; lymphotoxin-a
probe, 6FAM-TAMRAAGACTGCCCGTCAGCACCCCAATAMRA (Gene-
Bank accession no. NM_000660); CD11c forward, GCCACCGCCATC
CAAAA; CD11c reverse, TCCCTACGGGCCCCATAT; CD11c probe,
6FAM-TCGTGCACCGATTGTTCCATGCCT-TAMRA (GeneBank
accession no. NM_021334); DC-LAMP/LAMP3/CD208 forward,
TTGTCACCCAGGCTGGAGTAC; DCs-LAMP reverse, AATCACTT
GAACCCGGGAGG; DC-LAMP probe, 6FAM-TGGCACGATCTC
GGCTTATGGCAA-TAMRA (GeneBank accession no. AJ005766).
The RT-PCR reaction was performed using EZ PCR Core Reagents
(Applied Biosystems) according to the manufacturer’s directions and as
described previously (Haider et al., 2006).
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Tables with all gene lists can be downloaded from http://www.
rockefeller.edu/labheads/krueger/supplemental.php
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SUPPLEMENTARY MATERIAL
Table A1S. Genes expressed in keratinocytes.
Table A2S. Genes expressed in fibroblasts.
Table A3S. Genes expressed in macrophages.
Table A4S. Genes expressed in monocytes.
Table A5S. Genes expressed in T cells.
Table A6S. Genes expressed in iDCs, mDCs or both.
Table A7S. Genes expressed commonly in myeloid derived cells (monocytes,
macrophages, iDCs and mDCs).
Table A8S. Genes expressed in skin-resident cells (fibroblasts and keratino-
cytes).
Table A9S. Genes expressed in leukocytes (T cells, monocytes, macrophages,
iDCs and mDCs).
Table A10S. Genes expressed in multiple cells (more than one cell type).
Table A11S. Housekeeping genes: expressed with o1.5 expression levels in
all cell types.
Table A12S. Activation genes in PBMCs as compared to T cells.
Table A 13–15 S. Genes induced by IFN-g and TNF in keratinocytes at 1, 4, 24
or 48-hours post treatment.
Table B1S. Genes upregulated in psoriasis and cell typed.
Table B2S. Unique activation genes upregulated in psoriasis.
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